The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

Dr Mohammad Mahmoud shares anticipated updates on evolving local treatments, PSMA-based therapies, and impactful genetic studies.

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

In a powerful talk with Mathew Knowles and Courtney Bugler, CEO of Zero Prostate Cancer, we highlight the urgent need for awareness among Black men at risk.

The 10-year absolute risk of prostate cancer in relation to polygenic risk ... low cost while detecting progression at a curable stage. 36 Approximately 30 to 40% of persons undergoing active ...